@article{ea6ff60915e7436b85accd35632f8264,
title = "Biomarker-based assessment of collagen cross-linking identifies patients at risk of heart failure more likely to benefit from spironolactone effects on left atrial remodelling. Insights from the HOMAGE clinical trial",
keywords = "Heart failure, Spironolactone, Atrial remodelling, Collagen cross-linking, PRESERVED EJECTION FRACTION, MAGNETIC-RESONANCE, EXERCISE CAPACITY, VOLUME, FIBROSIS, FIBRILLATION, DYSFUNCTION, SURVIVAL",
author = "S. Ravassa and B. Lopez and J.P. Ferreira and N. Girerd and E. Bozec and P. Pellicori and B. Mariottoni and F. Cosmi and M. Hazebroek and J.A.J. Verdonschot and J. Cuthbert and J. Petutschnigg and M.U. Moreno and S. Heymans and J.A. Staessen and B. Pieske and F. Edelmann and A.L. Clark and J.G.F. Cleland and F. Zannad and J. Diez and A. Gonzalez and {HOMAGE Trial Committees and Investigators}",
year = "2022",
month = feb,
doi = "10.1002/ejhf.2394",
language = "English",
volume = "24",
pages = "321--331",
journal = "European journal of heart failure",
issn = "1388-9842",
publisher = "Wiley",
number = "2",
}